Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Centers for Disease Control and Prevention Homepage (2023) Influenza (Flu), Stay Home When You Are Sick. Form of Item. https://www.cdc.gov/flu/business/stay-home-when-sick.htm. Accessed 11 Aug 2023
2. Dronova M, Ikeoka H, Itsumura N, Hirotsu N, Ansaripour A, Aballéa S, Onishi Y, Hill M, Igarashi A (2021) Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan. Curr Med Res Opin 37(7):1135–1148. https://doi.org/10.1080/03007995.2021.1914942
3. Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A (2018) Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 379(10):913–923. https://doi.org/10.1056/NEJMoa1716197
4. Ikematsu H, Hayden FG, Kawaguchi K, Kinoshita M, de Jong MD, Lee N, Takashima S, Noshi T, Tsuchiya K, Uehara T (2020) Baloxavir marboxil for prophylaxis against influenza in household contacts. N Engl J Med 383(4):309–320. https://doi.org/10.1056/NEJMoa1915341
5. Inoue T, Watanabe K, Chonabayashi N, Uetsuka Y (2005) Pharmacoeconomics of antiviral therapy for influenza in a Japanese hospital setting. Clin Drug Investig 25(1):49–63